{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:50:47Z","timestamp":1779281447379,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Lennert lymphoma (LeL) is a variant of peripheral T-cell lymphoma, not otherwise specified. Few clinicopathologic studies have investigated LeL, which is a rare disease. Here, we analyzed the clinicopathologic features of 26 patients with LeL to identify potential prognostic factors. Neoplastic cells positive for CD4, CD8, CD4\/CD8, TIA-1, and granzyme B were observed in 21 (80.8%), 4 (15.4%), 1 (3.8%), 4 (15.3%), and 0 (0.0%) patients, respectively. Regarding follicular helper T-cell (T<jats:sub>FH<\/jats:sub>) markers, neoplastic cells positive for programmed cell death-1 (PD-1), CXCL13, CD10, and BCL6 were observed in 14 (53.8%), 13 (50.0%), 1 (3.8%), and 0 (0.0%) patients, respectively. Patients with positivity for at least 1 T<jats:sub>FH<\/jats:sub> cell marker (PD-1, CXCL13, CD10, and\/or BCL6) were defined as being T<jats:sub>FH<\/jats:sub> cell marker\u2013positive (n=15) and had a worse prognosis than T<jats:sub>FH<\/jats:sub> cell marker\u2013negative patients (n=11) (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.011). Clinicopathologic characteristics did not differ significantly between T<jats:sub>FH<\/jats:sub> cell marker\u2013positive and marker\u2013negative LeL patients. Moreover, prognosis did not differ significantly between T<jats:sub>FH<\/jats:sub> cell marker\u2013positive LeL patients and patients with angioimmunoblastic T-cell lymphoma (AITL) (n=42). Nevertheless, as compared with AITL, T<jats:sub>FH<\/jats:sub> cell marker\u2013positive LeL was associated with significantly lower frequencies of B symptoms, skin rash, high-intermediate-risk or high-risk international prognostic index values, expanded follicular dendritic cell meshworks, polymorphic infiltrate, clear cells, and positivity for CD10 and BCL6. Although it may be difficult to definitively distinguish between T<jats:sub>FH<\/jats:sub> cell marker\u2013positive LeL and AITL, our results suggest that T<jats:sub>FH<\/jats:sub> cell markers are useful for identifying LeL patients who will experience unfavorable outcomes.<\/jats:p>","DOI":"10.1097\/pas.0000000000000694","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T15:29:55Z","timestamp":1468510195000},"page":"1249-1260","source":"Crossref","is-referenced-by-count":28,"title":["A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors"],"prefix":"10.1097","volume":"40","author":[{"given":"Daisuke","family":"Kurita","sequence":"first","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"},{"name":"Department of Medicine, Division of Hematology and Rheumatology"},{"name":"Department of Biomedical Sciences, Division of Biochemistry, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Niino","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology and Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Division of Biochemistry, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood.V68.3.663.663","article-title":"Lymphoepithelioid lymphoma (Lennert's lymphoma) is a monoclonal proliferation of helper\/inducer T cells","volume":"68","author":"Feller","year":"1986","journal-title":"Blood"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.1986.tb02208.x","article-title":"T-cell origin of Lennert's lymphoma","volume":"64","author":"O'Connor","year":"1986","journal-title":"Br J Haematol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00000478-198805000-00002","article-title":"Histological and immunohistological findings in lymphoepithelioid cell lymphoma (Lennert's lymphoma)","volume":"12","author":"Patsouris","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/1097-0142(19910515)67:10<2565::AID-CNCR2820671029>3.0.CO;2-4","article-title":"A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma. Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma","volume":"67","author":"Nakamura","year":"1991","journal-title":"Cancer"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1993.tb03079.x","article-title":"Lymphoepithelioid cell lymphoma (Lennert\u2019s lymphoma): clinical features derived from analysis of 108 cases","volume":"84","author":"Patsouris","year":"1993","journal-title":"Br J Haematol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1994.tb08308.x","article-title":"Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group","volume":"87","author":"Siegert","year":"1994","journal-title":"Br J Haematol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00000478-200012000-00006","article-title":"Lennert's lymphoma: a variant of cytotoxic T-cell lymphoma?","volume":"24","author":"Yamashita","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00428-004-1077-2","article-title":"Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells","volume":"445","author":"Geissinger","year":"2004","journal-title":"Virchows Arch"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1440-1827.2005.01880.x","article-title":"Aggressive Lennert's lymphoma: report of three cases in comparison to non-aggressive Lennert's lymphoma","volume":"55","author":"Kitamura","year":"2005","journal-title":"Pathol Int"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00277-012-1642-8","article-title":"Successful allogeneic stem cell transplantation for Lennert lymphoma","volume":"92","author":"Uni","year":"2013","journal-title":"Ann Hematol"},{"key":"R12-20230922","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J Exp Med"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nri1714","article-title":"Follicular B helper T cells in antibody responses and autoimmunity","volume":"5","author":"Vinuesa","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2009.03.003","article-title":"Follicular helper T cells: lineage and location","volume":"30","author":"Fazilleau","year":"2009","journal-title":"Immunity"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/imr.12031","article-title":"T-cell subsets in the germinal center","volume":"252","author":"Ramiscal","year":"2013","journal-title":"Immunol Rev"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bjh.12941","article-title":"Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment","volume":"166","author":"Ahearne","year":"2014","journal-title":"Br J Haematol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers","volume":"32","author":"Rodriguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000478-198904000-00002","article-title":"Angioimmunoblastic lymphadenopathy--type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma","volume":"13","author":"Patsouris","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1309\/AJCPBPNV86VZENGV","article-title":"Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders","volume":"137","author":"Miyoshi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1827.2010.02514.x","article-title":"Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma (AITL)","volume":"60","author":"Niino","year":"2010","journal-title":"Pathol Int"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2559.2011.04069.x","article-title":"Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays?","volume":"59","author":"Hartmann","year":"2011","journal-title":"Histopathology"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jcp.2010.084459","article-title":"Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases","volume":"64","author":"Zhan","year":"2011","journal-title":"J Clin Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified","volume":"19","author":"Grogg","year":"2006","journal-title":"Mod Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1309\/AJCP62WRKERPXDRT","article-title":"Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma","volume":"131","author":"Yu","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/1097-0142(19920515)69:10<2571::AID-CNCR2820691030>3.0.CO;2-S","article-title":"A phenotypic and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma","volume":"69","author":"Takagi","year":"1992","journal-title":"Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:23:36Z","timestamp":1695421416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00010"}},"subtitle":["The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000694","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}